VOA News examines Foundation's efforts to treat MDR-TB patients in North Korea

Nov 15 2011

VOA News examines the Eugene Bell Foundation's work in North Korea to detect and treat patients with multiple-drug resistant tuberculosis (MDR-TB). The foundation is treating about 600 patients in North Korea, where "[c]onditions ... are ideal for the spread of TB. The climate is cold. Most citizens live and work in small spaces, and lack proper nutrition to maintain a strong immune system," VOA writes (Herman, 11/11).

    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Posted in: Disease/Infection News | Healthcare News

    Tags: , , , , , ,

    Comments (0)

    Suggested Reading

    Quabodepistat combo shows promise for safer, faster tuberculosis treatment
    Study finds high risk of pediatric tuberculosis in high-burden areas
    Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis
    TB pathogen's surprising growth mechanism challenges bacterial biology
    AI-driven surveillance system to combat emerging infectious diseases
    UMass Amherst researcher receives $2.2 million grant to study tuberculosis response
    Brazil's cash transfer program cuts tuberculosis cases and deaths among vulnerable populations
    WHO reports alarming rise in tuberculosis cases in 2023

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    (Logout)
    Post

    Newsletters you may be interested in

    See all Newsletters »

    Terms

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    Provide Feedback

    You might also like...
    New antibiotic shows promise in fighting tuberculosis